Mumbai, Dec 26 (IANS) Quick commerce company Zepto saw its losses widen significantly in the financial year 2024–25 (FY25) even as its sales more than doubled.According to the company’s audited financial statements, Zepto reported total sales of Rs 9,668.8 crore in FY25, a sharp jump of 129 per cent from Rs 4,223.9 crore in FY24.However, its net loss expanded much faster, rising 177 per cent year-on-year (YoY) to Rs 3,367.3 crore, compared with a loss of Rs 1,214.7 crore in the previous year…
Latest revenue News & Updates
New Delhi, Dec 25 (IANS) Sun Pharma’s US arm, Taro Pharmaceutical Industries, has recalled more than 17,000 units of antifungal over manufacturing issues, the US Food and Drug Administration (USFDA) has said.The Ciclopirox Shampoo — an antifungal medication that treats seborrheic dermatitis (a condition that causes dry, flaky, and itchy skin) — is being recalled due to “failed impurity/degradation specifications”, the USFDA said, in its latest Enforcement Report.The Class II nationwide r…